Search

everythinglearnresearchcommunity

for

Search:↓

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Healthcare providers need better education and policies to serve transgender individuals effectively.

The new visual scale is a quick and effective way to measure hair loss in women.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Hair regrowth doesn't convert thin hairs to thick hairs, but increases overall hair density.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

PRP injections improve hair thickness and density in hair loss, but more research needed.

Dutasteride and finasteride affect different cell types differently.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Microneedling with 5% minoxidil improves hair loss in Chinese men by activating Wnt/ß-catenin pathway.

Finasteride may cause kidney damage.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.